Kisspeptin (10mg Vial) Dosage Protocol

Overview

Research protocol outlining study-based dosing for stimulating GnRH, LH, and FSH release via once-daily subcutaneous injections.

What is Kisspeptin?

Kisspeptin, also called metastin, is a naturally occurring neuroendocrine peptide crucial for human reproductive function. It activates the GPR54 receptor in the hypothalamus, triggering pulsatile GnRH (gonadotropin-releasing hormone) release. This downstream effect stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion. Originally identified as a metastasis-suppressor gene product, kisspeptin has become significant in reproductive endocrinology research.

Mechanism of Action

Upon subcutaneous injection, kisspeptin binds to GPR54 receptors on GnRH neurons in the hypothalamus, causing immediate GnRH release. This subsequently stimulates anterior pituitary secretion of LH and FSH, which act on the gonads to enhance sex steroid production and support gametogenesis. Importantly, kisspeptin’s mechanism is GnRH-dependent — if GnRH release is blocked, kisspeptin cannot induce LH/FSH secretion, making it more physiologic than direct GnRH or hCG administration.

Reconstitution Instructions

Standard Approach:
– Add 3.0 mL bacteriostatic water to the 10mg vial
– Target concentration: ~3.33 mg/mL
– Inject water slowly down vial wall; avoid foaming
– Gently swirl/roll until fully dissolved (do not shake)
– Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light

Easy Measuring:
– At 3.33 mg/mL concentration, 1 unit on U-100 insulin syringe = 0.01 mL ≈ 33.3 mcg

Dosing Protocol

Frequency: Once daily subcutaneous injection

Duration: 8–12 weeks with gradual titration; avoid prolonged continuous use to prevent tachyphylaxis

Timing: Any consistent time daily; rotate injection sites

Dosing Approach

– Start: 100 mcg daily for 1–2 weeks to assess sensitivity
– Titrate: Increase to 200 mcg daily if tolerated
– Administration: Subcutaneous injection once per day
– Cycle: 8–12 weeks; avoid extended continuous use

Storage Instructions

Lyophilized Form:
– Store at −20 °C (−4 °F) in dry, dark conditions with desiccant if possible

Reconstituted:
– Refrigerate at 2–8 °C (35.6–46.4 °F)
– Stable approximately 4 weeks
– Avoid freeze-thaw cycles
– Allow vials to reach room temperature before opening to reduce condensation

Bacteriostatic Water:
– Discard after 28 days once opened

Supplies Needed (8-16 Week Protocol)

Kisspeptin Vials:
– 8 weeks: 1 vial
– 12 weeks: 2 vials
– 16 weeks: 3 vials

Insulin Syringes (U-100):
– 8 weeks: 56 syringes
– 12 weeks: 84 syringes
– 16 weeks: 112 syringes

Bacteriostatic Water:
– 1 x 10 mL bottle per vial reconstitution

Alcohol Swabs:
– 8 weeks: 112 swabs (recommend 2 x 100-count boxes)
– 12 weeks: 168 swabs (recommend 2 x 100-count boxes)
– 16 weeks: 224 swabs (recommend 3 x 100-count boxes)

Potential Benefits

– Physiological Sex Hormone Stimulation: Increases endogenous testosterone and estrogen by amplifying the body’s own LH/FSH signals without suppressing the HPG axis
– Fertility Restoration: Shows promise in functional hypothalamic amenorrhea by restoring GnRH/LH pulsatility and resuming menstrual cycles
– IVF Ovulation Trigger: Can induce robust LH surge to mature oocytes with potentially lower ovarian hyperstimulation syndrome (OHSS) risk compared to traditional hCG triggers
– Safety Profile: Generally well tolerated; occasional mild injection-site reactions (redness/itching) may occur with subcutaneous administration

Side Effects

Limited adverse effects documented:
– Occasional mild injection-site reactions (redness, itching)
– Generally well-tolerated with subcutaneous administration

Injection Technique

Best Practices:
– Clean vial stopper and skin with alcohol; allow to dry completely
– Pinch a skinfold; insert needle at 45–90° into subcutaneous tissue (45° for thin individuals, 90° with adequate fat)
– Do not aspirate for subcutaneous injections
– Inject slowly and steadily
– Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms, upper buttocks) to avoid tissue irritation
– Use new sterile syringe for each injection; dispose in sharps container

Lifestyle Factors

– Maintain adequate nutrition and healthy body weight to support endogenous hormone production
– Prioritize sleep and stress management, as these significantly impact the HPG axis
– Monitor for changes in reproductive function or hormone-related symptoms
– Consider combining with appropriate lifestyle interventions for hypothalamic suppression conditions

Important Notes

– Use new sterile insulin syringes; dispose properly in sharps container
– Rotate injection sites to reduce local irritation
– Inject slowly; wait seconds before withdrawing needle
– Document daily dose and site rotation for consistency
– For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability
– This protocol is for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment

Disclaimer

This content is intended for educational and research purposes only. Always consult a qualified healthcare professional before beginning any research protocol. For research use only.